Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Innoviz Technologies
INVZ
$114M
| $1.05M | ﹤0.01% |
181,796
+59,554
| +49% | +$469K |
|
3652
Eagle Bancorp Montana
EBMT
$189M
| $1.04M | ﹤0.01% |
46,508
+2,897
| +7% | +$64.4K |
|
|
OPTN
3653
DELISTED
OptiNose
OPTN
| $1.04M | ﹤0.01% |
23,080
+1,189
| +5% | +$49.9K |
|
3654
Xponential Fitness
XPOF
$206M
| $1.04M | ﹤0.01% |
+81,733
| New | +$949K |
|
3655
Arq
ARQ
$99.6M
| $1.03M | ﹤0.01% |
161,896
+1,221
| +0.8% | +$8.4K |
|
3656
Schwab International Equity ETF
SCHF
$69.3B
| – | – |
0
| – | – |
|
|
HLTH
3657
DELISTED
Cue Health Inc. Common Stock
HLTH
| $1.03M | ﹤0.01% |
+87,034
| New | +$1.37M |
|
3658
ENI
E
$79.1B
| $1.03M | ﹤0.01% |
38,370
+2,471
| +7% | +$60.2K |
|
3659
Team
TISI
$101M
| $1.02M | ﹤0.01% |
34,018
-13,366
| -28% | -$644K |
|
3660
Woori Financial
WF
$17.2B
| $1.02M | ﹤0.01% |
35,423
-1,390
| -4% | -$40.3K |
|
3661
RxSight
RXST
$292M
| $1.02M | ﹤0.01% |
+80,578
| New | +$1.11M |
|
|
FNCB
3662
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $1.02M | ﹤0.01% |
122,849
+3,220
| +3% | +$24.9K |
|
3663
Corvus Pharmaceuticals
CRVS
$1.27B
| $1.02M | ﹤0.01% |
210,243
+20,702
| +11% | +$61.3K |
|
|
OPGN
3664
DELISTED
OpGen, Inc
OPGN
| $1.02M | ﹤0.01% |
1,766
+164
| +10% | +$89.2K |
|
3665
Honda
HMC
$40.5B
| $1.02M | ﹤0.01% |
33,141
-1,189
| -3% | -$37.4K |
|
3666
Aprea Therapeutics
APRE
$8.31M
| $1.01M | ﹤0.01% |
9,917
+4,695
| +90% | +$426K |
|
3667
Arqit Quantum
ARQQ
$413M
| $1.01M | ﹤0.01% |
+2,021
| New | +$1M |
|
|
ODT
3668
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $1.01M | ﹤0.01% |
348,433
+62,945
| +22% | +$209K |
|
3669
Culp Inc
CULP
$43.2M
| $1.01M | ﹤0.01% |
78,525
+1,064
| +1% | +$15K |
|
3670
Orion Energy Systems
OESX
$78.9M
| $1.01M | ﹤0.01% |
25,964
+473
| +2% | +$21.8K |
|
3671
Viridian Therapeutics
VRDN
$2.49B
| $1.01M | ﹤0.01% |
61,250
+22,967
| +60% | +$337K |
|
|
HEPA
3672
DELISTED
Hepion Pharmaceuticals
HEPA
| $1.01M | ﹤0.01% |
658
+7
| +1% | +$11.2K |
|
3673
Genprex
GNPX
$2.46M
| $1M | ﹤0.01% |
9
+1
| +13% | +$129K |
|
3674
Talphera
TLPH
$62.8M
| $1M | ﹤0.01% |
49,263
-3,277
| -6% | -$75.1K |
|
3675
KB Financial Group
KB
$41.7B
| $1M | ﹤0.01% |
21,614
-84
| -0.4% | -$3.8K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.